 | • レポートコード：QYR9ST02389 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のシクロスポリン市場について調査・分析し、以下の構成でお届け致します。シクロスポリンの種類別には、丸薬、経口液に、用途別には、病院、クリニックに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別シクロスポリン売上データ ・地域別シクロスポリン市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別シクロスポリン市場規模：丸薬、経口液 ・用途別シクロスポリン市場規模：病院、クリニック ・主要メーカーの企業情報：Alcon、Allergan、Herantis Pharma、Mimetogen Pharmaceuticals、Mitotech、Otsuka Pharmaceutical、Regenerx Biopharmaceuticals、Santen Pharmaceutical、Shire、United Biotech ・シクロスポリンの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Cyclosporine is an immunosuppressant medicine and natural product administered via injection and mouth into veins for the treatment of rheumatoid psoriasis, arthritis, nephrotic syndrome, Crohn’s disease, and in organ transplants to prevent rejection.In addition, it is used as eye drops for dry eyes. Ciclosporin was extracted from the fungus Tolypocladium inflatum, and was eventually used for medicinal purposes.
The global Cyclosporine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cyclosporine market based on company, product type, end user and key regions.
This report studies the global market size of Cyclosporine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cyclosporine in these regions.
This research report categorizes the global Cyclosporine market by top players/brands, region, type and end user. This report also studies the global Cyclosporine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alcon
Allergan
Herantis Pharma
Mimetogen Pharmaceuticals
Mitotech
Otsuka Pharmaceutical
Regenerx Biopharmaceuticals
Santen Pharmaceutical
Shire
United Biotech
Market size by Product
Pills
Oral Liquid
Market size by End User
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cyclosporine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cyclosporine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cyclosporine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cyclosporine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cyclosporine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cyclosporine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Cyclosporine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Cyclosporine Market Size Growth Rate by Product
1.4.2 Pills
1.4.3 Oral Liquid
1.5 Market by End User
1.5.1 Global Cyclosporine Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cyclosporine Market Size
2.1.1 Global Cyclosporine Revenue 2014-2025
2.1.2 Global Cyclosporine Sales 2014-2025
2.2 Cyclosporine Growth Rate by Regions
2.2.1 Global Cyclosporine Sales by Regions
2.2.2 Global Cyclosporine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Cyclosporine Sales by Manufacturers
3.1.1 Cyclosporine Sales by Manufacturers
3.1.2 Cyclosporine Sales Market Share by Manufacturers
3.1.3 Global Cyclosporine Market Concentration Ratio (CR5 and HHI)
3.2 Cyclosporine Revenue by Manufacturers
3.2.1 Cyclosporine Revenue by Manufacturers (2014-2019)
3.2.2 Cyclosporine Revenue Share by Manufacturers (2014-2019)
3.3 Cyclosporine Price by Manufacturers
3.4 Cyclosporine Manufacturing Base Distribution, Product Types
3.4.1 Cyclosporine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cyclosporine Product Type
3.4.3 Date of International Manufacturers Enter into Cyclosporine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Cyclosporine Sales by Product
4.2 Global Cyclosporine Revenue by Product
4.3 Cyclosporine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Cyclosporine Breakdown Data by End User
6 North America
6.1 North America Cyclosporine by Countries
6.1.1 North America Cyclosporine Sales by Countries
6.1.2 North America Cyclosporine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Cyclosporine by Product
6.3 North America Cyclosporine by End User
7 Europe
7.1 Europe Cyclosporine by Countries
7.1.1 Europe Cyclosporine Sales by Countries
7.1.2 Europe Cyclosporine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cyclosporine by Product
7.3 Europe Cyclosporine by End User
8 Asia Pacific
8.1 Asia Pacific Cyclosporine by Countries
8.1.1 Asia Pacific Cyclosporine Sales by Countries
8.1.2 Asia Pacific Cyclosporine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Cyclosporine by Product
8.3 Asia Pacific Cyclosporine by End User
9 Central & South America
9.1 Central & South America Cyclosporine by Countries
9.1.1 Central & South America Cyclosporine Sales by Countries
9.1.2 Central & South America Cyclosporine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Cyclosporine by Product
9.3 Central & South America Cyclosporine by End User
10 Middle East and Africa
10.1 Middle East and Africa Cyclosporine by Countries
10.1.1 Middle East and Africa Cyclosporine Sales by Countries
10.1.2 Middle East and Africa Cyclosporine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Cyclosporine by Product
10.3 Middle East and Africa Cyclosporine by End User
11 Company Profiles
11.1 Alcon
11.1.1 Alcon Company Details
11.1.2 Company Business Overview
11.1.3 Alcon Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Alcon Cyclosporine Products Offered
11.1.5 Alcon Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Business Overview
11.2.3 Allergan Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Allergan Cyclosporine Products Offered
11.2.5 Allergan Recent Development
11.3 Herantis Pharma
11.3.1 Herantis Pharma Company Details
11.3.2 Company Business Overview
11.3.3 Herantis Pharma Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Herantis Pharma Cyclosporine Products Offered
11.3.5 Herantis Pharma Recent Development
11.4 Mimetogen Pharmaceuticals
11.4.1 Mimetogen Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Mimetogen Pharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Mimetogen Pharmaceuticals Cyclosporine Products Offered
11.4.5 Mimetogen Pharmaceuticals Recent Development
11.5 Mitotech
11.5.1 Mitotech Company Details
11.5.2 Company Business Overview
11.5.3 Mitotech Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Mitotech Cyclosporine Products Offered
11.5.5 Mitotech Recent Development
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Otsuka Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Otsuka Pharmaceutical Cyclosporine Products Offered
11.6.5 Otsuka Pharmaceutical Recent Development
11.7 Regenerx Biopharmaceuticals
11.7.1 Regenerx Biopharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Regenerx Biopharmaceuticals Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Regenerx Biopharmaceuticals Cyclosporine Products Offered
11.7.5 Regenerx Biopharmaceuticals Recent Development
11.8 Santen Pharmaceutical
11.8.1 Santen Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Santen Pharmaceutical Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Santen Pharmaceutical Cyclosporine Products Offered
11.8.5 Santen Pharmaceutical Recent Development
11.9 Shire
11.9.1 Shire Company Details
11.9.2 Company Business Overview
11.9.3 Shire Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Shire Cyclosporine Products Offered
11.9.5 Shire Recent Development
11.10 United Biotech
11.10.1 United Biotech Company Details
11.10.2 Company Business Overview
11.10.3 United Biotech Cyclosporine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 United Biotech Cyclosporine Products Offered
11.10.5 United Biotech Recent Development
12 Future Forecast
12.1 Cyclosporine Market Forecast by Regions
12.1.1 Global Cyclosporine Sales Forecast by Regions 2019-2025
12.1.2 Global Cyclosporine Revenue Forecast by Regions 2019-2025
12.2 Cyclosporine Market Forecast by Product
12.2.1 Global Cyclosporine Sales Forecast by Product 2019-2025
12.2.2 Global Cyclosporine Revenue Forecast by Product 2019-2025
12.3 Cyclosporine Market Forecast by End User
12.4 North America Cyclosporine Forecast
12.5 Europe Cyclosporine Forecast
12.6 Asia Pacific Cyclosporine Forecast
12.7 Central & South America Cyclosporine Forecast
12.8 Middle East and Africa Cyclosporine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cyclosporine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Cyclosporine Product Picture
Table Cyclosporine Market Segments
Table Key Manufacturers Cyclosporine Covered
Table Global Cyclosporine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Cyclosporine Sales Market Share by Product 2014-2025
Figure Pills Product Picture
Table Major Manufacturers of Pills
Figure Oral Liquid Product Picture
Table Major Manufacturers of Oral Liquid
Table Global Cyclosporine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Cyclosporine Report Years Considered
Figure Global Cyclosporine Market Size 2014-2025 (Million US$)
Figure Global Cyclosporine Sales 2014-2025 (K Units)
Table Global Cyclosporine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Cyclosporine Sales by Regions 2014-2019 (K Units)
Table Global Cyclosporine Sales Market Share by Regions 2014-2019
Figure Global Cyclosporine Sales Market Share by Regions 2014-2019
Figure 2018 Global Cyclosporine Sales Market Share by Regions
Table Global Cyclosporine Revenue by Regions 2014-2019 (Million US$)
Table Global Cyclosporine Revenue Market Share by Regions 2014-2019
Figure Global Cyclosporine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Cyclosporine Revenue Market Share by Regions
Table Global Cyclosporine Sales by Manufacturers (2014-2019) (K Units)
Table Global Cyclosporine Sales Share by Manufacturers (2014-2019)
Figure Global Cyclosporine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Cyclosporine Revenue by Manufacturers (2014-2019) (Million USD)
Table Cyclosporine Revenue Share by Manufacturers (2014-2019)
Figure Cyclosporine Value Share by Manufacturers in 2018
Table Key Manufacturers Cyclosporine Price (2014-2019) (USD/Unit)
Table Cyclosporine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Cyclosporine Product Type
Table Date of International Manufacturers Enter into Cyclosporine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Cyclosporine Sales by Product (2014-2019) (K Units)
Table Global Cyclosporine Sales Share by Product (2014-2019)
Figure Global Cyclosporine Sales Market Share by Product (2014-2019)
Figure Global Cyclosporine Sales Market Share by Product in 2018
Table Global Cyclosporine Revenue by Product (2014-2019) (Million US$)
Table Global Cyclosporine Revenue Share by Product (2014-2019)
Figure Global Cyclosporine Revenue Market Share by Product (2014-2019)
Figure Global Cyclosporine Revenue Market Share by Product in 2018
Table Cyclosporine Price by Product 2014-2019 (USD/Unit)
Table Global Cyclosporine Sales by End User (2014-2019) (K Units)
Table Global Cyclosporine Sales Share by End User (2014-2019)
Figure Global Sales Cyclosporine Market Share by End User (2014-2019)
Figure Global Sales Cyclosporine Market Share by End User in 2018
Figure North America Cyclosporine Sales Growth Rate 2014-2019 (K Units)
Figure North America Cyclosporine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Cyclosporine Sales by Countries (2014-2019) (K Units)
Table North America Cyclosporine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Cyclosporine Sales Market Share by Countries
Table North America Cyclosporine Revenue by Countries (2014-2019) (Million US$)
Table North America Cyclosporine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Cyclosporine Revenue Market Share by Countries
Figure United States Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure United States Cyclosporine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Cyclosporine Sales by Product (2014-2019) (K Units)
Table North America Cyclosporine Sales Market Share by Product (2014-2019)
Figure 2018 North America Cyclosporine Market Share by Product
Table North America Cyclosporine Sales by End User (2014-2019) (K Units)
Table North America Cyclosporine Sales Market Share by End User (2014-2019)
Figure 2018 North America Cyclosporine Market Share by End User
Figure Europe Cyclosporine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Cyclosporine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Cyclosporine Sales by Countries (2014-2019) (K Units)
Table Europe Cyclosporine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Cyclosporine Sales Market Share by Countries
Table Europe Cyclosporine Revenue by Countries (2014-2019) (Million US$)
Table Europe Cyclosporine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Cyclosporine Revenue Market Share by Countries
Figure Germany Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure France Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure UK Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Cyclosporine Sales by Product (2014-2019) (K Units)
Table Europe Cyclosporine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Cyclosporine Market Share by Product
Table Europe Cyclosporine Sales by End User (2014-2019) (K Units)
Table Europe Cyclosporine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Cyclosporine Market Share by End User
Figure Asia Pacific Cyclosporine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Cyclosporine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Cyclosporine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Cyclosporine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cyclosporine Sales Market Share by Countries
Table Asia Pacific Cyclosporine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Cyclosporine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Cyclosporine Revenue Market Share by Countries
Figure China Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure China Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure India Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Cyclosporine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Cyclosporine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Cyclosporine Market Share by Product
Table Asia Pacific Cyclosporine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Cyclosporine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Cyclosporine Market Share by End User
Figure Central & South America Cyclosporine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Cyclosporine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Cyclosporine Sales by Countries (2014-2019) (K Units)
Table Central & South America Cyclosporine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cyclosporine Sales Market Share by Countries
Table Central & South America Cyclosporine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Cyclosporine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Cyclosporine Revenue Market Share by Countries
Figure Brazil Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Cyclosporine Sales by Product (2014-2019) (K Units)
Table Central & South America Cyclosporine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Cyclosporine Market Share by Product
Table Central & South America Cyclosporine Sales by End User (2014-2019) (K Units)
Table Central & South America Cyclosporine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Cyclosporine Market Share by End User
Figure Middle East and Africa Cyclosporine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Cyclosporine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Cyclosporine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Cyclosporine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cyclosporine Sales Market Share by Countries
Table Middle East and Africa Cyclosporine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Cyclosporine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Cyclosporine Revenue Market Share by Countries
Figure GCC Countries Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Cyclosporine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Cyclosporine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Cyclosporine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Cyclosporine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Cyclosporine Market Share by Product
Table Middle East and Africa Cyclosporine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Cyclosporine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Cyclosporine Market Share by End User
Table Alcon Company Details
Table Alcon Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alcon Recent Development
Table Allergan Company Details
Table Allergan Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Herantis Pharma Company Details
Table Herantis Pharma Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Herantis Pharma Recent Development
Table Mimetogen Pharmaceuticals Company Details
Table Mimetogen Pharmaceuticals Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mimetogen Pharmaceuticals Recent Development
Table Mitotech Company Details
Table Mitotech Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mitotech Recent Development
Table Otsuka Pharmaceutical Company Details
Table Otsuka Pharmaceutical Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Otsuka Pharmaceutical Recent Development
Table Regenerx Biopharmaceuticals Company Details
Table Regenerx Biopharmaceuticals Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Regenerx Biopharmaceuticals Recent Development
Table Santen Pharmaceutical Company Details
Table Santen Pharmaceutical Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Santen Pharmaceutical Recent Development
Table Shire Company Details
Table Shire Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Recent Development
Table United Biotech Company Details
Table United Biotech Cyclosporine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table United Biotech Recent Development
Table Global Cyclosporine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Cyclosporine Sales Market Share Forecast by Regions 2019-2025
Table Global Cyclosporine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Cyclosporine Revenue Market Share Forecast by Regions 2019-2025
Table Global Cyclosporine Sales Forecast by Product 2019-2025 (K Units)
Table Global Cyclosporine Sales Market Share Forecast by Product 2019-2025
Table Global Cyclosporine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Cyclosporine Revenue Market Share Forecast by Product 2019-2025
Table Global Cyclosporine Sales Forecast by End User 2019-2025 (K Units)
Table Global Cyclosporine Sales Market Share Forecast by End User 2019-2025
Figure North America Cyclosporine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Cyclosporine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Cyclosporine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Cyclosporine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Cyclosporine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Cyclosporine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Cyclosporine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Cyclosporine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Cyclosporine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Cyclosporine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Cyclosporine Value Chain
Table Cyclosporine Customers List
Table Cyclosporine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
緊急避妊薬の世界市場：インサイト・予測 Emergency contraception is an important component of a comprehensive family planning program. It can help reduce the chance of unintended pregnancy following unprotected intercourse, contraceptive failure or misuse or in cases of sexual assault. It also helps to empower women, as it expands the meth…- スマートピルの世界市場：インサイト・予測 Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted drug delivery.They are majorly available in the form of a vitamin capsule sized pill and possess sm…
- 赤ちゃん用口腔衛生の世界市場：インサイト・予測 This market study report demonstrates a detailed segmentation of the global baby oral care market by product type such as toothpaste and toothbrush and segmented by regions such as the Americas, APAC, Europe, and MEA. The key vendors in the market are Church & Dwight, Colgate-Palmolive, Johnson & Jo…
- 経口制御放出ドラッグデリバリーテクノロジーの世界市場：インサイト・予測 The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes.…
- 院内感染肺炎予防の世界市場：インサイト・予測 HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…